403 related articles for article (PubMed ID: 17694350)
21. Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model.
Parkinson WM; Dookwah M; Dear ML; Gatto CL; Aoki K; Tiemeyer M; Broadie K
Dis Model Mech; 2016 May; 9(5):513-27. PubMed ID: 26940433
[TBL] [Abstract][Full Text] [Related]
22. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of novel mutations in a congenital disorder of glycosylation Ia patient with mixed Asian ancestry.
Westphal V; Enns GM; McCracken MF; Freeze HH
Mol Genet Metab; 2001 May; 73(1):71-6. PubMed ID: 11350185
[TBL] [Abstract][Full Text] [Related]
24. Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts.
Sharma V; Ichikawa M; He P; Scott DA; Bravo Y; Dahl R; Ng BG; Cosford ND; Freeze HH
J Biol Chem; 2011 Nov; 286(45):39431-8. PubMed ID: 21949237
[TBL] [Abstract][Full Text] [Related]
25. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype.
Monin ML; Mignot C; De Lonlay P; Héron B; Masurel A; Mathieu-Dramard M; Lenaerts C; Thauvin C; Gérard M; Roze E; Jacquette A; Charles P; de Baracé C; Drouin-Garraud V; Khau Van Kien P; Cormier-Daire V; Mayer M; Ogier H; Brice A; Seta N; Héron D
Orphanet J Rare Dis; 2014 Dec; 9():207. PubMed ID: 25497157
[TBL] [Abstract][Full Text] [Related]
26. Carbohydrate-deficient glycoprotein syndrome: beyond the screen.
Fletcher JM; Matthijs G; Jaeken J; Van Schaftingen E; Nelson PV
J Inherit Metab Dis; 2000 Jun; 23(4):396-8. PubMed ID: 10896303
[No Abstract] [Full Text] [Related]
27. Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic.
Damen G; de Klerk H; Huijmans J; den Hollander J; Sinaasappel M
J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):282-7. PubMed ID: 15076627
[TBL] [Abstract][Full Text] [Related]
28. Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG).
Thiesler CT; Cajic S; Hoffmann D; Thiel C; van Diepen L; Hennig R; Sgodda M; Weiβmann R; Reichl U; Steinemann D; Diekmann U; Huber NM; Oberbeck A; Cantz T; Kuss AW; Körner C; Schambach A; Rapp E; Buettner FF
Mol Cell Proteomics; 2016 Apr; 15(4):1435-52. PubMed ID: 26785728
[TBL] [Abstract][Full Text] [Related]
29. Congenital disorder of glycosylation type Ia in a Malaysian family: clinical outcome and description of a novel PMM2 mutation.
Thong MK; Fietz M; Nicholls C; Lee MH; Asma O
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S41-4. PubMed ID: 19165618
[TBL] [Abstract][Full Text] [Related]
30. Genotypes and estimated prevalence of phosphomannomutase 2 deficiency in Turkey differ significantly from those in Europe.
Yıldız Y; Arslan M; Çelik G; Kasapkara ÇS; Ceylaner S; Dursun A; Sivri HS; Coşkun T; Tokatlı A
Am J Med Genet A; 2020 Apr; 182(4):705-712. PubMed ID: 31981409
[TBL] [Abstract][Full Text] [Related]
31. "Hide and seek": Misleading transferrin variants in PMM2-CDG complicate diagnostics.
Raynor A; Bruneel A; Vermeersch P; Cholet S; Friedrich S; Eckenweiler M; Schumann A; Hengst S; Tuncel AT; Fenaille F; Thiel C; Rymen D
Proteomics Clin Appl; 2024 Mar; 18(2):e2300040. PubMed ID: 37876147
[TBL] [Abstract][Full Text] [Related]
32. Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency.
Shanti B; Silink M; Bhattacharya K; Howard NJ; Carpenter K; Fietz M; Clayton P; Christodoulou J
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S241-51. PubMed ID: 19396570
[TBL] [Abstract][Full Text] [Related]
33. [CDG (congenital disorders of glycosylation). Differential hereditary ataxia in adulthood diagnosis].
Bubel S; Peters V; Klein C; Hackler R; Schaefer JR; Hagenah J; Hoffmann GF; Vieregge P
Nervenarzt; 2002 Aug; 73(8):754-60. PubMed ID: 12242963
[TBL] [Abstract][Full Text] [Related]
34. Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts.
Sala G; Dupré T; Seta N; Codogno P; Ghidoni R
Pediatr Res; 2002 Nov; 52(5):645-51. PubMed ID: 12409508
[TBL] [Abstract][Full Text] [Related]
35. Congenital Disorder of Glycosylation (CDG) Presenting as Non-immune Hydrops Fetalis.
Panigrahy N; Lingappa L; Ramadevi AR; Venkatlakshmi A
Indian J Pediatr; 2016 Apr; 83(4):359-60. PubMed ID: 26365158
[No Abstract] [Full Text] [Related]
36. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
[TBL] [Abstract][Full Text] [Related]
37. CDG type Ia and congenital cytomegalovirus infection: two coexisting conditions.
Jamroz E; Adamek D; Paprocka J; Adamowicz M; Marszał E; Wevers RA
J Child Neurol; 2009 Jan; 24(1):13-8. PubMed ID: 19168813
[TBL] [Abstract][Full Text] [Related]
38. Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.
Erlandson A; Bjursell C; Stibler H; Kristiansson B; Wahlström J; Martinsson T
Hum Genet; 2001 May; 108(5):359-67. PubMed ID: 11409861
[TBL] [Abstract][Full Text] [Related]
39. A novel mutation and first report of dilated cardiomyopathy in ALG6-CDG (CDG-Ic): a case report.
Al-Owain M; Mohamed S; Kaya N; Zagal A; Matthijs G; Jaeken J
Orphanet J Rare Dis; 2010 Apr; 5():7. PubMed ID: 20398363
[TBL] [Abstract][Full Text] [Related]
40. A novel PMCA3 mutation in an ataxic patient with hypomorphic phosphomannomutase 2 (PMM2) heterozygote mutations: Biochemical characterization of the pump defect.
Vicario M; Calì T; Cieri D; Vallese F; Bortolotto R; Lopreiato R; Zonta F; Nardella M; Micalizzi A; Lefeber DJ; Valente EM; Bertini E; Zanotti G; Zanni G; Brini M; Carafoli E
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3303-3312. PubMed ID: 28807751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
